Proton Pump Inhibitors Market: How Are PPIs Used in NSAID Gastroprotection?
NSAID-associated gastrointestinal toxicity represents a major indication driving substantial PPI prescribing volume, with the Proton Pump Inhibitors Market reflecting the clinical evidence supporting PPI co-prescription for gastroprotection in the enormous population of patients receiving chronic NSAID therapy for arthritis, musculoskeletal pain, and cardiovascular prevention who carry...
0 Comments 0 Shares 17 Views 0 Reviews